FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Rifampin Injection
Status: Currently in Shortage
»Date first posted: 02/17/2021
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (Reverified 04/30/2021)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
600 mg per vial, PF, Lyophilized powder (NDC 63323-351-20) Available

Mylan Institutional, a Viatris company (Revised 04/27/2021)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
600 mg, (Lyophilizate in Single Dose Vials) (NDC 67457-445-60) Intermittent supply Demand increase for the drug

Sanofi (Revised 04/08/2021)

Company Contact Information:
800-633-1610

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
600 mg/10 mL, Lyophilized powder (NDC 0068-0597-01) Available Requirements related to complying with good manufacturing practices

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English